140 related articles for article (PubMed ID: 17786184)
1. Optical imaging of tumor cells in hollow fibers: evaluation of the antitumor activities of anticancer drugs and target validation.
Zhang GJ; Chen TB; Bednar B; Connolly BM; Hargreaves R; Sur C; Williams DL
Neoplasia; 2007 Aug; 9(8):652-61. PubMed ID: 17786184
[TBL] [Abstract][Full Text] [Related]
2. Bioluminescence imaging of hollow fibers in living animals: its application in monitoring molecular pathways.
Zhang GJ; Chen TB; Hargreaves R; Sur C; Williams DL
Nat Protoc; 2008; 3(5):891-9. PubMed ID: 18451797
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
Suggitt M; Swaine DJ; Pettit GR; Bibby MC
Clin Cancer Res; 2004 Oct; 10(19):6677-85. PubMed ID: 15475458
[TBL] [Abstract][Full Text] [Related]
4. The hollow fiber assay: continued characterization with novel approaches.
Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs.
Phillips RM; Pearce J; Loadman PM; Bibby MC; Cooper PA; Swaine DJ; Double JA
Cancer Res; 1998 Dec; 58(23):5263-6. PubMed ID: 9850044
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay.
Li XL; Liu JY; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Jia J; Fu Z; Yao Z
Invest New Drugs; 2008 Dec; 26(6):525-9. PubMed ID: 18264678
[TBL] [Abstract][Full Text] [Related]
7. Use of the Hollow Fiber Assay to Evaluate Agents That Target the Tumor Neovasculature.
Cooper PA; Shnyder SD
Methods Mol Biol; 2016; 1430():375-86. PubMed ID: 27172968
[TBL] [Abstract][Full Text] [Related]
8. A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828.
Hassan SB; de la Torre M; Nygren P; Karlsson MO; Larsson R; Jonsson E
Anticancer Drugs; 2001 Jan; 12(1):33-42. PubMed ID: 11272284
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulated tumor assay: new short-term assay for in vivo evaluation of the effects of anticancer drugs on human tumor cell lines.
Gorelik E; Ovejera A; Shoemaker R; Jarvis A; Alley M; Duff R; Mayo J; Herberman R; Boyd M
Cancer Res; 1987 Nov; 47(21):5739-47. PubMed ID: 3664478
[TBL] [Abstract][Full Text] [Related]
10. The hollow fiber assay.
Hall LA; Krauthauser CM; Wexler RS; Slee AM; Kerr JS
Methods Mol Med; 2003; 74():545-66. PubMed ID: 12415720
[No Abstract] [Full Text] [Related]
11. Noninvasive bioluminescence imaging of the dynamics of sanguinarine induced apoptosis via activation of reactive oxygen species.
Wang Y; Zhang B; Liu W; Dai Y; Shi Y; Zeng Q; Wang F
Oncotarget; 2016 Apr; 7(16):22355-67. PubMed ID: 26968950
[TBL] [Abstract][Full Text] [Related]
12. Application of molecular imaging technology in evaluating the inhibiting effect of apigenin in vivo on subcutaneous hepatocellular carcinoma.
Li G; Chi CW; Shao XF; Fang CH
Biochem Biophys Res Commun; 2017 May; 487(1):122-127. PubMed ID: 28408212
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
McMillin DW; Delmore J; Weisberg E; Negri JM; Geer DC; Klippel S; Mitsiades N; Schlossman RL; Munshi NC; Kung AL; Griffin JD; Richardson PG; Anderson KC; Mitsiades CS
Nat Med; 2010 Apr; 16(4):483-9. PubMed ID: 20228816
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of antitumor drug sensitivity between marrow mesenchymal stem cells (MSCs) and hepatocarcinoma cells in rats].
Zhou SL; Li P; Cao MM; Zhang JR
Ai Zheng; 2006 Aug; 25(8):979-82. PubMed ID: 16965678
[TBL] [Abstract][Full Text] [Related]
15. Optical Bioluminescence Protocol for Imaging Mice.
Stout D; David J
Methods Mol Biol; 2018; 1790():29-40. PubMed ID: 29858781
[TBL] [Abstract][Full Text] [Related]
16. Antitumour efficacy of Piper tuberculatum and piplartine based on the hollow fiber assay.
Bezerra DP; Ferreira PM; Machado CM; de Aquino NC; Silveira ER; Chammas R; Pessoa C
Planta Med; 2015 Jan; 81(1):15-9. PubMed ID: 25519832
[TBL] [Abstract][Full Text] [Related]
17. The hollow fibre model in cancer drug screening: the NCI experience.
Decker S; Hollingshead M; Bonomi CA; Carter JP; Sausville EA
Eur J Cancer; 2004 Apr; 40(6):821-6. PubMed ID: 15120037
[TBL] [Abstract][Full Text] [Related]
18. Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
Mi Q; Pezzuto JM; Farnsworth NR; Wani MC; Kinghorn AD; Swanson SM
J Nat Prod; 2009 Mar; 72(3):573-80. PubMed ID: 19161316
[TBL] [Abstract][Full Text] [Related]
19. [Effect of 5 drugs with different antitumor mechanism on tumor-formation potential of rat hepatocarcinoma cells and mesenchymal stem cells].
Zhou Y; Luo M; Zhang J; Zhang WQ; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):290-2. PubMed ID: 17425974
[TBL] [Abstract][Full Text] [Related]
20. A new in vivo assay of the reactions of microencapsulated human tumor cells to chemotherapeutic drugs.
Hwang JM; Chen CF; Hsu WL; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Mar; 51(3):166-75. PubMed ID: 8490790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
